| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.80B | 24.70B | 25.36B | 26.88B | 25.46B |
| Gross Profit | 10.96B | 11.71B | 12.33B | 14.07B | 11.82B |
| EBITDA | 2.23B | 2.24B | 2.20B | 3.28B | 4.44B |
| Net Income | 1.90B | 1.88B | 1.85B | 2.42B | 3.23B |
Balance Sheet | |||||
| Total Assets | 743.99B | 676.37B | 630.71B | 591.51B | 574.98B |
| Cash, Cash Equivalents and Short-Term Investments | 74.77B | 44.79B | 33.80B | 30.80B | 40.52B |
| Total Debt | 216.98B | 110.57B | 102.52B | 95.27B | 90.45B |
| Total Liabilities | 697.12B | 620.07B | 576.39B | 538.89B | 515.57B |
| Stockholders Equity | 45.08B | 54.45B | 52.45B | 50.77B | 57.77B |
Cash Flow | |||||
| Free Cash Flow | 13.61B | 8.49B | -10.56B | -32.09B | -43.32B |
| Operating Cash Flow | 13.70B | 8.77B | -10.04B | -31.35B | -42.62B |
| Investing Cash Flow | -17.85B | -11.96B | -4.03B | 27.51B | 40.96B |
| Financing Cash Flow | -2.88B | 5.10B | 15.57B | -7.07B | 3.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$16.27B | 7.00 | 7.72% | 3.57% | 4.05% | 13.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | HK$15.90B | 3.98 | 5.60% | 5.32% | -6.83% | 2.10% | |
60 Neutral | HK$15.24B | 1.84 | 4.62% | 6.13% | -3.62% | 1.69% | |
58 Neutral | HK$11.70B | 2.96 | 3.11% | 4.24% | -6.16% | 4.83% | |
57 Neutral | HK$15.10B | 2.83 | 4.11% | ― | -7.67% | 21.16% | |
54 Neutral | HK$16.01B | -6.21 | 3.77% | 1.89% | ― | ― |